Today, the SVP of Finance of Intuitive Surgical (ISRG), Jamie Samath, sold shares of ISRG for $238.1K.
Following Jamie Samath’s last ISRG Sell transaction on April 22, 2020, the stock climbed by 146.0%.
See today’s analyst top recommended stocks >>
Based on Intuitive Surgical’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $1.1 billion and quarterly net profit of $314 million. In comparison, last year the company earned revenue of $974 million and had a net profit of $307 million. The company has a one-year high of $675.06 and a one-year low of $360.50. ISRG’s market cap is $76.75 billion and the company has a P/E ratio of 57.50.
Based on 15 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $657.50, reflecting a 1.8% upside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Read More on ISRG:
